Ariana Pharma
PrivateLast Round
Grant
Apr 16, 2024
Total Funding Raised
$27.91M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ariana Pharma is a biotechnology company that develops AI-driven software and decision support systems to optimize clinical trials and drug development.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Drug Discovery, Healthcare Analytics, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ariana Pharma Comparables
Compare Ariana Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BullFrog AI Holdings, Inc. | 77% | |
| BenevolentAI | 76% | |
| QuantHealth | 72% |
Ariana Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 16, 2024 | ||||
| Grant | Mar 1, 2024 | ||||
| Grant | Apr 29, 2020 | ||||
| Grant | Oct 13, 2009 | ||||
| Series A | Jul 8, 2008 | ||||
Seed | Nov 3, 2005 |
Ariana Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eurostars SME programme | Grant |
| Institut Imagine | Grant |
| Aventis Foundation | Seed |
| Institut Pasteur | Series A, Seed |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 196% MoM, reaching 761.
- Apr 3, 2026
Monthly visitors grew 33% MoM.
Ariana Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ariana Pharma's valuation, stock price, and market status.
Is Ariana Pharma a public or private company?
Ariana Pharma is a private company.
What is the current stock price of Ariana Pharma?
Ariana Pharma is a private company, so its shares have no public market price. Caplight tracks Ariana Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ariana Pharma worth (valuation)?
Valuation information for Ariana Pharma is not publicly available.
Can I buy Ariana Pharma stock?
Ariana Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ariana Pharma's last funding round?
Ariana Pharma's most recent funding round was Grant on April 16, 2024.
Who are the main investors in Ariana Pharma?
Key investors in Ariana Pharma include Eurostars SME programme, Aventis Foundation, Institut Pasteur.
Will Ariana Pharma IPO soon?
No public IPO plans have been announced for Ariana Pharma.
How can I track Ariana Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Ariana Pharma's shares on secondary markets.